An interferon lambda 4-associated variant in the hepatitis C virus RNA polymerase affects viral replication in infected cells

References

1. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 2013; 45:164–171 [View Article][PubMed]
   [Google Scholar]
2. Ansari MA, Pedergnana V, L C Ip C, Magri A, Von Delft A et al. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nat Genet 2017; 49:666–673 [View Article][PubMed]
   [Google Scholar]
3. Ansari MA, Aranday-Cortes E, Ip CLC, da Silva Filipe A, Lau SH et al. Interferon lambda 4 impacts the genetic diversity of hepatitis C virus. eLife 2019; 8:e42463 [View Article][PubMed]
   [Google Scholar]
4. Chaturvedi N, Svarovskaia ES, Mo H, Osinusi AO, Brainard DM et al. Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes. eLife 2019; 8:e42542 [View Article][PubMed]
   [Google Scholar]
5. Selisko B, Papageorgiou N, Ferron F, Canard B. Structural and functional basis of the fidelity of nucleotide selection by flavivirus RNA-dependent RNA polymerases. Viruses 2018; 10:59 [View Article][PubMed]
   [Google Scholar]
6. Bressanelli S, Tomei L, Roussel A, Incitti I, Vitale RL et al. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci U S A 1999; 96:13034–13039 [View Article][PubMed]
   [Google Scholar]
7. Domingues P, Bamford CGG, Boutell C, McLauchlan J. Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase. J Gen Virol 2015; 96:3236–3242 [View Article][PubMed]
   [Google Scholar]
8. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006; 103:7408–7413 [View Article][PubMed]
   [Google Scholar]
9. Rose R, Markov PV, Lam TT, Pybus OG. Viral evolution explains the associations among hepatitis C virus genotype, clinical outcomes, and human genetic variation. Infect Genet Evol 2013; 20:418–421 [View Article][PubMed]
   [Google Scholar]
10. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A 2006; 103:3805–3809 [View Article][PubMed]
    [Google Scholar]
11. Bamford CGG, Aranday-Cortes E, Filipe IC, Sukumar S, Mair D et al. A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages. PLoS Pathog 2018; 14:e1007307 [View Article][PubMed]
    [Google Scholar]
12. Ben Ouirane K, Boulard Y, Bressanelli S. The hepatitis C virus RNA-dependent RNA polymerase directs incoming nucleotides to its active site through magnesium-dependent dynamics within its F motif. J Biol Chem 2019; 294:7573–7587 [View Article][PubMed]
    [Google Scholar]
13. Gouklani H, Bull RA, Beyer C, Coulibaly F, Gowans EJ et al. Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis. J Virol 2012; 86:5080–5088 [View Article][PubMed]
    [Google Scholar]
14. Dujardin M, Cantrelle F-X, Lippens G, Hanoulle X. Interaction study between HCV NS5A-D2 and NS5B using 19F NMR. J Biomol NMR 2018; 70:67–76 [View Article][PubMed]
    [Google Scholar]
15. Wing PAC, Jones M, Cheung M, DaSilva S, Bamford C et al. Amino acid substitutions in genotype 3A hepatitis C virus polymerase protein affect responses to sofosbuvir. Gastroenterology 2019; 157:692–704 [View Article][PubMed]
    [Google Scholar]